Financial Advocates Investment Management Pfizer Inc Transaction History

Financial Advocates Investment Management

$1.78 Billion
Q3 2024

A detailed history of Financial Advocates Investment Management transactions in Pfizer Inc stock. As of the latest transaction made, Financial Advocates Investment Management holds 44,909 shares of PFE stock, worth $1.19 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

44,909

Previous 1,000 4390.9%

Holding current value

$1.19 Million

Previous $27,000 4711.11%

% of portfolio

0.07%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$27.7 - $31.39 $37,699 - $42,721	1,361 Added 3.13%	44,909 $1.3 Million
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $165,932 - $194,442	-6,569 Reduced 13.11%	43,548 $1.22 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $162,097 - $186,139	6,261 Added 14.28%	50,117 $1.39 Million
Q4 2023 Feb 08, 2024	BUY	$26.13 - $33.94 $35,510 - $46,124	1,359 Added 3.2%	43,856 $1.26 Million
Q3 2023 Oct 27, 2023	BUY	$32.09 - $37.51 $41,941 - $49,025	1,307 Added 3.17%	42,497 $1.41 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $17,482 - $20,226	484 Added 1.19%	41,190 $1.51 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $95,441 - $124,251	-2,423 Reduced 5.62%	40,706 $1.66 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $205,451 - $268,194	-4,921 Reduced 10.24%	43,129 $2.21 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $57,588 - $70,300	1,316 Added 2.82%	48,050 $2.1 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $289,881 - $343,709	-6,230 Reduced 11.76%	46,734 $2.45 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $50,325 - $62,359	-1,100 Reduced 2.03%	52,964 $2.74 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $10,949 - $16,231	-265 Reduced 0.49%	54,064 $3.19 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $350,149 - $449,796	-8,921 Reduced 14.1%	54,329 $2.34 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $36,233 - $41,046	-1,009 Reduced 1.57%	63,250 $2.48 Million
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $49,096 - $55,370	-1,466 Reduced 2.23%	64,259 $2.33 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $164,337 - $208,969	4,910 Added 8.07%	65,725 $2.42 Million
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $175,164 - $205,508	5,517 Added 9.98%	60,815 $2.23 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $107,016 - $129,826	3,553 Added 6.87%	55,298 $1.81 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $532,923 - $761,431	-19,716 Reduced 27.59%	51,745 $1.69 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $11,324 - $12,851	344 Added 0.48%	71,461 $2.8 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $489,364 - $634,562	15,062 Added 26.87%	71,117 $2.56 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $72,887 - $81,835	1,971 Added 3.64%	56,055 $2.43 Million
Q1 2019 May 16, 2019	SELL	$37.5 - $41.2 $525 - $576	-14 Reduced 0.03%	54,084 $2.3 Million
Q4 2018 May 09, 2019	SELL	$38.47 - $43.86 $1.93 Million - $2.2 Million	-50,050 Reduced 48.06%	54,098 $2.36 Million
Q4 2018 Mar 04, 2019	BUY	$38.47 - $43.86 $1.93 Million - $2.2 Million	50,050 Added 92.52%	104,148 $3.64 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $339,767 - $387,371	-8,832 Reduced 14.03%	54,098 $2.24 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $235,912 - $286,147	6,844 Added 12.2%	62,930 $0
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $258,101 - $275,162	-7,826 Reduced 12.24%	56,086 $2.04 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $271,937 - $315,484	8,522 Added 15.39%	63,912 $2.27 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $1.84 Million - $1.95 Million	55,390	55,390 $2.01 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.

Account

Financial Advocates Investment Management Pfizer Inc Transaction History